Concepedia

Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level

Valérie Boige, Mohamed Hebbar, David Malka, Thierry Debaere, L Hannoun, E. Magherini, D. Mignard, Thierry Poynard, Michel Ducreux

European Journal of Cancer · 2006 · 65 citations · 11 references

DOI

Concepts

References

11

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.8K citations

, , +13

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix, Morris Sherman, Josep M. Llovet et al. · Journal of Hepatology · 2001 · 4.1K citations

, , +10

The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

Edmund A. Gehan · Journal of Chronic Diseases · 1961 · 668 citations

, , +7

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

Philippe Rougier, R. Bugat, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 1997 · 429 citations

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

G G Chabot, D Abigerges, G. Catimel et al. · Annals of Oncology · 1995 · 172 citations

, , +5